Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China · Delayed Price · Currency is CNY 13.22
+0.09 (0.69%)
Jul 29, 2026, 3:04 PM CST
SHE:002275 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,104 | 2,046 | 2,194 | 2,172 | 1,960 | 1,741 |
Revenue Growth | -3.38% | -6.76% | 1.03% | 10.81% | 12.55% | 11.15% |
Gross Profit Gross Profit Growth | 1,606 | 1,537 | 1,584 | 1,569 | 1,385 | 1,284 |
Operating Income Operating Income Growth | 533.5 | 514.23 | 485.33 | 460.41 | 315.65 | 326.37 |
Net Income Net Income Growth | 452.67 | 433.13 | 521.53 | 421.3 | 329.53 | 343.72 |
Earnings Per Share EPS Growth | 0.77 | 0.74 | 0.89 | 0.72 | 0.56 | 0.60 |
EPS Growth | -14.48% | -16.85% | 23.61% | 28.57% | -6.67% | 25.00% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Industry Industry Growth | 1,964 | 2,121 | 2,098 | 1,869 | - |
Commodity Circulation (Commercial) Commodity Circulation (Commercial) Growth | 49.9 | 41.25 | 46.19 | 48.85 | 43.87 |
Other Business Other Business Growth | 31.37 | 31.75 | 27.41 | 42.15 | 18.38 |
Total Total Growth | 2,046 | 2,194 | 2,172 | 1,960 | 1,741 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,739 | 1,721 | 1,676 | 1,406 | 1,427 | 1,699 |
Total Debt Total Debt Growth | 439.78 | 513.78 | 593.63 | 528.33 | 465.88 | 609.1 |
Net Cash (Debt) Net Cash Growth | 1,299 | 1,208 | 1,082 | 877.86 | 961.07 | 1,090 |
Net Cash Growth | -1.11% | 11.59% | 23.27% | -8.66% | -11.86% | -18.50% |
Net Cash Per Share Net Cash Per Share Growth | 2.21 | 2.06 | 1.85 | 1.50 | 1.63 | 1.90 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 668.6 | 708.12 | 588.33 | 549.25 | 528.67 | 410.24 |
Capital Expenditures CapEx Growth | -83.76 | -86.94 | -82.18 | -76.4 | -62.27 | -144.09 |
Free Cash Flow Free Cash Flow Growth | 584.84 | 621.18 | 506.16 | 472.85 | 466.4 | 266.15 |
Free Cash Flow Growth | 12.56% | 22.72% | 7.04% | 1.38% | 75.24% | -32.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 76.34% | 75.14% | 72.17% | 72.25% | 70.69% | 73.75% |
Operating Margin | 25.35% | 25.14% | 22.12% | 21.20% | 16.11% | 18.74% |
Pretax Margin | 26.58% | 26.25% | 29.35% | 23.87% | 22.77% | 24.64% |
Profit Margin | 21.51% | 21.17% | 23.77% | 19.40% | 16.81% | 19.74% |
FCF Margin | 27.79% | 30.36% | 23.07% | 21.77% | 23.80% | 15.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.600 | 0.600 | 0.800 | 0.900 |
Dividend Per Share Growth | -16.67% | -16.67% | 0% | -25.00% | -11.11% | 125.00% |
Dividend Yield | 3.81% | 3.63% | 4.22% | 4.57% | 6.93% | 6.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 17.17 | 19.13 | 17.00 | 20.21 | 22.97 | 28.30 |
Forward PE | - | 17.06 | 18.63 | 15.39 | 16.92 | 16.92 |
P/FCF Ratio | 13.28 | 13.34 | 17.52 | 18.01 | 16.23 | 36.55 |
PS Ratio | 3.69 | 4.05 | 4.04 | 3.92 | 3.86 | 5.59 |